Finnish gelsolin amyloidosis causes significant disease burden but does not affect survival: FIN-GAR phase II study

Overview of attention for article published in Orphanet Journal of Rare Diseases, January 2020

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 24 Dimensions

Readers on

mendeley: 31 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 1,238 followers.

Finnish gelsolin amyloidosis causes significant disease burden but does not affect survival: FIN-GAR phase II study. #amchelsinki #tutkimus https://t.co/Tpxwbcoa7t

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.